ABILIFY- aripiprazole tablet ABILIFY- aripiprazole solution ABILIFY- aripiprazole tablet, orally disintegrating ABILIFY- arip Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

abilify- aripiprazole tablet abilify- aripiprazole solution abilify- aripiprazole tablet, orally disintegrating abilify- arip

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea

Boots Pharmaceuticals Day Cold & Flu Relief Hard Capsules Paracetamol 500 mg Pholcodine 5 mg Pseudoephedrine Hydrochloride 30 mg Irlanda - engleză - HPRA (Health Products Regulatory Authority)

boots pharmaceuticals day cold & flu relief hard capsules paracetamol 500 mg pholcodine 5 mg pseudoephedrine hydrochloride 30 mg

the boots company plc - paracetamol; pseudoephedrine hydrochloride; pholcodine - capsule, hard - 500/5/30 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

Boots Pharmaceuticals Diarrhoea Relief 2 mg Hard Capsules Irlanda - engleză - HPRA (Health Products Regulatory Authority)

boots pharmaceuticals diarrhoea relief 2 mg hard capsules

the boots company plc - loperamide hydrochloride - capsule, hard - 2 milligram(s) - antipropulsives; loperamide

LIVERPOOL 99 %v/v Granules Irlanda - engleză - HPRA (Health Products Regulatory Authority)

liverpool 99 %v/v granules

imb- test agent company - viburnum opulus - granules - 99 %v/v

Nanocis 0.24 mg kit for radiopharmaceutical preparation Irlanda - engleză - HPRA (Health Products Regulatory Authority)

nanocis 0.24 mg kit for radiopharmaceutical preparation

cis bio international - rhenium sulphide - kit for radiopharmaceutical preparation - milligram - technetium (99mtc), particles and colloids

OSTEOCIS 3mg kit for radiopharmaceutical preparation Irlanda - engleză - HPRA (Health Products Regulatory Authority)

osteocis 3mg kit for radiopharmaceutical preparation

cis bio international - sodium oxidronate - kit for radiopharmaceutical preparation - 3.0 milligram(s) - technetium (99mtc) compounds; technetium (99mtc) oxidronic acid

STAMICIS 1mg kit for radiopharmaceutical preparation Irlanda - engleză - HPRA (Health Products Regulatory Authority)

stamicis 1mg kit for radiopharmaceutical preparation

cis bio international - tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate - kit for radiopharmaceutical preparation - 1 milligram(s) - technetium (99mtc) compounds; technetium (99mtc) sestamibi

Technescan MIBI 1mg kit for radiopharmaceutical preparation Irlanda - engleză - HPRA (Health Products Regulatory Authority)

technescan mibi 1mg kit for radiopharmaceutical preparation

curium netherlands b.v. - tetrakis (2-methylopropyl-isocyanide) copper (i) tetrafluoroborate - kit for radiopharmaceutical preparation - 1 milligram(s) - technetium (99mtc) sestamibi

Revestive Uniunea Europeană - engleză - EMA (European Medicines Agency)

revestive

takeda pharmaceuticals international ag ireland branch - teduglutide - malabsorption syndromes - other alimentary tract and metabolism products, - revestive is indicated for the treatment of patients aged 1 year and above with short bowel syndrome (sbs). patients should be stable following a period of intestinal adaptation after surgery.revestive is indicated for the treatment of patients aged 1 year and above with short bowel syndrome. patients should be stable following a period of intestinal adaptation after surgery.

ANDROGEL Canada - engleză - Health Canada

androgel

bgp pharma ulc - testosterone - gel - 1% - testosterone 1% - androgens